Merck to Lower Prices on Some Drugs, but Not its Blockbusters

The drugs singled out for discounts include the flagging hepatitis C treatment Zepatier and six drugs that have lost their patent protection. KATIE THOMAS https://ift.tt/2zVJlJc https://ift.tt/2NvYlzg The New York Times Health Prices (Fares, Fees and Rates), Drugs (Pharmaceuticals) July 19, 2018 at 12:00AM